Satoh M - Search Results

1

DAMGO recognizes four residues in the third extracellular loop to discriminate between mu- and kappa-opioid receptors.

Seki T, Minami M, Nakagawa T, Ienaga Y, Morisada A, Satoh M. Seki T, et al. Among authors: satoh m. Eur J Pharmacol. 1998 Jun 5;350(2-3):301-10. doi: 10.1016/s0014-2999(98)00240-4. Eur J Pharmacol. 1998. PMID: 9696421

2

Intracisternal administration of interleukin-1 beta attenuates naloxone-precipitated withdrawal in morphine-dependent mice.

Katsumata S, Minami M, Nakagawa T, Satoh M. Katsumata S, et al. Among authors: satoh m. Eur J Pharmacol. 1995 May 15;278(2):143-50. doi: 10.1016/0014-2999(95)00112-x. Eur J Pharmacol. 1995. PMID: 7671998

3

DAMGO, a mu-opioid receptor selective ligand, distinguishes between mu-and kappa-opioid receptors at a different region from that for the distinction between mu- and delta-opioid receptors.

Minami M, Onogi T, Nakagawa T, Katao Y, Aoki Y, Katsumata S, Satoh M. Minami M, et al. Among authors: satoh m. FEBS Lett. 1995 May 1;364(1):23-7. doi: 10.1016/0014-5793(95)00340-f. FEBS Lett. 1995. PMID: 7750536 Free article.

4

[Opioid receptors--structures, functions and distributions].

Minami M, Satoh M. Minami M, et al. Among authors: satoh m. Seikagaku. 1994 Aug;66(8):1134-8. Seikagaku. 1994. PMID: 7963853 Review. Japanese. No abstract available.

5

DAMGO, a mu-opioid receptor selective agonist, distinguishes between mu- and delta-opioid receptors around their first extracellular loops.

Onogi T, Minami M, Katao Y, Nakagawa T, Aoki Y, Toya T, Katsumata S, Satoh M. Onogi T, et al. Among authors: satoh m. FEBS Lett. 1995 Jan 2;357(1):93-7. doi: 10.1016/0014-5793(94)01341-w. FEBS Lett. 1995. PMID: 8001688 Free article.

6

Molecular biology of the opioid receptors: structures, functions and distributions.

Minami M, Satoh M. Minami M, et al. Among authors: satoh m. Neurosci Res. 1995 Sep;23(2):121-45. doi: 10.1016/0168-0102(95)00933-k. Neurosci Res. 1995. PMID: 8532211 Review.

7

Pharmacological study of dihydroetorphine in cloned mu-, delta- and kappa-opioid receptors.

Katsumata S, Minami M, Nakagawa T, Iwamura T, Satoh M. Katsumata S, et al. Among authors: satoh m. Eur J Pharmacol. 1995 Nov 30;291(3):367-73. doi: 10.1016/0922-4106(95)90078-0. Eur J Pharmacol. 1995. PMID: 8719422

8

Molecular pharmacology of the opioid receptors.

Satoh M, Minami M. Satoh M, et al. Pharmacol Ther. 1995;68(3):343-64. doi: 10.1016/0163-7258(95)02011-x. Pharmacol Ther. 1995. PMID: 8788562 Review.

9

Pharmacological characterization of KT-90 using cloned mu-, delta- and kappa-opioid receptors.

Katsumata S, Ienaga Y, Minami M, Nakagawa T, Kanematsu K, Satoh M. Katsumata S, et al. Among authors: satoh m. Eur J Pharmacol. 1996 Oct 3;312(3):349-55. doi: 10.1016/0014-2999(96)00469-4. Eur J Pharmacol. 1996. PMID: 8894618

10

A single residue, Lys108, of the delta-opioid receptor prevents the mu-opioid-selective ligand [D-Ala2,N-MePhe4,Gly-ol5]enkephalin from binding to the delta-opioid receptor.

Minami M, Nakagawa T, Seki T, Onogi T, Aoki Y, Katao Y, Katsumata S, Satoh M. Minami M, et al. Among authors: satoh m. Mol Pharmacol. 1996 Nov;50(5):1413-22. Mol Pharmacol. 1996. PMID: 8913373

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,917 results

Search Page

Filters